MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

Strona główna・Stock List・Fortrea Holdings Inc.

Fortrea Holdings Inc.

Closed

SectorHealthcare

17.07 0.29

Buy Sell

Overview

Share price change

24h

Current

Min

16.66

Max

17.17

Key metrics
By Trading Economics
Income	359M -16M
Sales	-9M 701M
EPS	0.12
Profit margin	-2.267
Employees	14,500
EBITDA	341M 14M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	-5.22% downside

Dividends
By Dow Jones
Next Earnings	2 mar 2026

Market Stats
By TradingEconomics
Market Cap	606M 1.5B
Previous open	16.78
Previous close	17.07

News Sentiment

By Acuity

50%

148 / 352 Ranking in Healthcare

Fortrea Holdings Inc. Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 sty 2026, 23:07 UTC

Earnings

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27 sty 2026, 21:27 UTC

Earnings

Texas Instruments 4Q Sales Rise, Profit Falls

27 sty 2026, 23:55 UTC

Market Talk

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27 sty 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 sty 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27 sty 2026, 23:39 UTC

Market Talk

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27 sty 2026, 23:20 UTC

Earnings

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27 sty 2026, 23:20 UTC

Earnings

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27 sty 2026, 23:19 UTC

Earnings

SK Innovation Posts Net Loss for Second Consecutive Year

27 sty 2026, 23:19 UTC

Earnings

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27 sty 2026, 23:18 UTC

Earnings

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27 sty 2026, 23:18 UTC

Earnings

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27 sty 2026, 23:11 UTC

Market Talk

Global Equities Roundup: Market Talk

27 sty 2026, 23:11 UTC

Market Talk

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27 sty 2026, 23:07 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27 sty 2026, 22:17 UTC

Market Talk

U.S. Dollar Slips Following Trump Comments -- Market Talk

27 sty 2026, 22:06 UTC

Earnings

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27 sty 2026, 21:51 UTC

Earnings

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 sty 2026, 21:43 UTC

Earnings

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27 sty 2026, 21:41 UTC

Earnings

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27 sty 2026, 21:38 UTC

Earnings

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27 sty 2026, 21:32 UTC

Earnings

Ampol: Modest Profit From F&I International in 2025

27 sty 2026, 21:32 UTC

Earnings

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27 sty 2026, 21:31 UTC

Earnings

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27 sty 2026, 21:31 UTC

Earnings

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27 sty 2026, 21:30 UTC

Earnings

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27 sty 2026, 21:29 UTC

Earnings

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27 sty 2026, 21:29 UTC

Earnings

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27 sty 2026, 21:28 UTC

Earnings

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Peer Comparison

Price change

Fortrea Holdings Inc. Forecast

Price Target

By TipRanks

-5.22% downside

12 Months Forecast

Average 16.17 USD -5.22%

High 25 USD

Low 8 USD

Based on 9 Wall Street analysts offering 12 month price targets forFortrea Holdings Inc. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

Buy

Hold

Sell

Based on 9 analysts giving stock ratings to Fortrea Holdings Inc. - Dist in the past 3 months.

Sentiment

By Acuity

148 / 352 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.